XML 29 R9.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Oct. 24, 2015
Oct. 25, 2014
OPERATING ACTIVITIES:    
Net income $ 30,824 $ 20,807
Adjustments to reconcile net income to net cash (used in) provided by operating activities, net of acquisitions:    
Depreciation and amortization 27,449 22,930
Deferred income tax benefit (3,971) (3,465)
Stock-based compensation 4,509 3,890
Bad debt expense, net 490 83
Gain on sale of fixed assets (1,136) (1,523)
Write-off of deferred financing fees and premium on long-term debt 2,017 0
Amortization of debt discount 1,780 0
Amortization of premium on long-term debt (94) (97)
Amortization of debt issuance costs and other 690 494
Excess tax benefit from share-based awards (1,024) (210)
Change in operating assets and liabilities:    
Accounts receivable, net (35,497) (22,016)
Costs and estimated earnings in excess of billings, net (51,342) (26,237)
Other current assets and inventory (9,296) (1,608)
Other assets (844) (159)
Income taxes receivable/payable 12,598 10,233
Accounts payable 7,875 1,151
Accrued liabilities, insurance claims, and other liabilities (13,890) 6,632
Net cash (used in) provided by operating activities (28,862) 10,905
INVESTING ACTIVITIES:    
Cash paid for acquisitions, net of cash acquired (48,596) (8,371)
Capital expenditures (40,758) (18,028)
Proceeds from sale of assets 1,327 1,698
Changes in restricted cash (479) (541)
Net cash used in investing activities (88,506) (25,242)
FINANCING ACTIVITIES:    
Proceeds from borrowings on senior credit agreement, including term loan 317,000 132,000
Principal payments on senior credit agreement, including term loan (281,000) (122,344)
Proceeds from issuance of 0.75% senior convertible notes due 2021 485,000 0
Proceeds from sale of warrants 74,690 0
Purchase of convertible note hedge (115,818) 0
Principal payments for satisfaction and discharge of 7.125% senior subordinated notes (277,500) 0
Debt issuance costs (14,494) 0
Repurchases of common stock (69,997) 0
Exercise of stock options 139 567
Restricted stock tax withholdings (1,168) (309)
Excess tax benefit from share-based awards 1,024 210
Net cash provided by financing activities 117,876 10,124
Net increase (decrease) in cash and equivalents 508 (4,213)
CASH AND EQUIVALENTS AT BEGINNING OF PERIOD 21,289 20,672
CASH AND EQUIVALENTS AT END OF PERIOD 21,797 16,459
Cash paid during the period for:    
Interest 6,866 1,369
Income taxes 11,444 6,796
Purchases of capital assets included in accounts payable or other accrued liabilities at period end 7,805 3,924
Non-cash debt issuance costs $ 993 $ 0